Last reviewed: June 8, 2026 Last updated: June 8, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
However, the clinical approach to stopping tirzepatide depends on your underlying conditionwhether type 2 diabetes or chronic weight managementand requires careful medical planning
GLP-1 medications are designed for long-term use, and many patients benefit from staying on them indefinitely or taking breaks and restarting as needed
To address these concerns and sustain the progress made, many healthcare providers recommend transitioning to a maintenance dose rather than discontinuing treatment altogether
American guidelines generally treat obesity as a chronic condition requiring ongoing management, without specifying a maximum duration
The body fights to return to its previous set point with remarkable persistence